Boehringer Ingelheim & Eko Health ink digital health collaboration to improve heart murmur detection in dogs: Ingelheim, Germany Wednesday, June 11, 2025, 10:00 Hrs [IST] Boehring ...

AMMOI opposes IMA's call to stop govt initiative to start integrated medical course at JIPMER in Pondicherry: Peethaambaran Kunnathoor, Chennai Wednesday, June 11, 2025, 08:00 Hrs ...

AI-powered CX solutions making healthcare more equitable, accessible, efficient & human-centric: Maureen Chong: Shardul Nautiyal, Mumbai Wednesday, June 11, 2025, 08:00 Hrs [IST] ...

Indian healthcare sees increasing need to integrate technology for diagnostics to gain traction: Nandita Vijayasimha, Bengaluru Wednesday, June 11, 2025, 08:00 Hrs [IST] Indian he ...

The Laghu Udyog Bharati (LUB), an association of small and micro enterprises headquartered in New Delhi, has recently urged the Union Health Minister to consider a further extension of the deadline, ...

Gelatin capsules give way to HPMC capsules as capsule market shifts towards vegan alternatives: Nandita Vijayasimha, Bengaluru Wednesday, June 11, 2025, 08:00 Hrs [IST] India’s ...

DoP modifies guidelines on capacity building scheme for medical devices: Gireesh Babu, New Delhi Wednesday, June 11, 2025, 08:00 Hrs [IST] The Department of Pharmaceuticals (DoP) ...

Since then, the NIMHANS team has been providing regular clinical services to these underserved patients. Nearly 2/3rds of these patients were out-of-treatment, and our team has provided services to ...

WuXi Biologics & VISEN Pharmaceuticals partner to manufacture lonapegsomatropin at Chengdu microbial manufacturing site: Chengdu Tuesday, June 10, 2025, 15:00 Hrs [IST] WuXi Biolo ...

Harrow acquires US commercial rights to Byqlovi 0.05% from Formosa Pharma: Nashville, Tennessee Tuesday, June 10, 2025, 14:00 Hrs [IST] Harrow, a leading North American eyecare ph ...

Apollo Cradle & Children’s Hospital set for significant expansion, plans 7-8 new centres in the next five years: Our Bureau, Bengaluru Tuesday, June 10, 2025, 17:10 Hrs [IST] Ap ...

Everest Medicines presents positive results in preliminary analysis of phase 1b/2a trial of novel BTK inhibitor EVER001 at ERA 2025 Congress: Shanghai, China Tuesday, June 10, 202 ...